Company Quick10K Filing
Illumina
10-Q 2020-06-28 Filed 2020-08-07
10-Q 2020-03-29 Filed 2020-05-01
10-K 2019-12-29 Filed 2020-02-11
10-Q 2019-09-29 Filed 2019-10-25
10-Q 2019-06-30 Filed 2019-07-31
10-Q 2019-03-31 Filed 2019-04-26
10-K 2018-12-30 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-10-24
10-Q 2018-07-01 Filed 2018-07-31
10-Q 2018-04-01 Filed 2018-04-25
10-K 2017-12-31 Filed 2018-02-13
10-Q 2017-10-01 Filed 2017-10-25
10-Q 2017-07-02 Filed 2017-08-03
10-Q 2017-04-02 Filed 2017-05-05
10-K 2017-01-01 Filed 2017-02-14
10-Q 2016-10-02 Filed 2016-11-08
10-Q 2016-07-03 Filed 2016-08-02
10-Q 2016-04-03 Filed 2016-05-09
10-K 2016-01-03 Filed 2016-03-02
10-Q 2015-09-27 Filed 2015-11-02
10-Q 2015-06-28 Filed 2015-07-31
10-Q 2015-03-29 Filed 2015-05-01
10-K 2014-12-28 Filed 2015-02-18
10-Q 2014-09-28 Filed 2014-10-29
10-Q 2014-06-29 Filed 2014-08-01
10-Q 2014-03-30 Filed 2014-05-07
10-K 2013-12-29 Filed 2014-02-18
10-Q 2013-09-29 Filed 2013-11-06
10-Q 2013-06-30 Filed 2013-07-29
10-Q 2013-03-31 Filed 2013-05-01
10-K 2012-12-30 Filed 2013-02-15
10-Q 2012-07-01 Filed 2012-07-30
10-Q 2012-04-01 Filed 2012-05-03
10-K 2012-01-01 Filed 2012-02-24
10-Q 2011-10-02 Filed 2011-11-04
10-Q 2011-07-03 Filed 2011-08-10
10-Q 2011-04-03 Filed 2011-05-04
10-K 2011-01-02 Filed 2011-02-28
10-Q 2010-10-03 Filed 2010-11-05
10-Q 2010-07-04 Filed 2010-08-04
10-Q 2010-04-04 Filed 2010-04-30
10-K 2010-01-03 Filed 2010-02-26
8-K 2020-08-19 Officers
8-K 2020-08-06 Earnings, Exhibits
8-K 2020-05-27
8-K 2020-05-06
8-K 2020-04-30
8-K 2020-04-14
8-K 2020-02-04
8-K 2020-01-29
8-K 2020-01-13
8-K 2020-01-02
8-K 2019-12-18
8-K 2019-11-25
8-K 2019-10-24
8-K 2019-09-25
8-K 2019-08-27
8-K 2019-07-29
8-K 2019-07-11
8-K 2019-06-18
8-K 2019-05-29
8-K 2019-04-25
8-K 2019-02-05
8-K 2019-01-29
8-K 2019-01-07
8-K 2018-10-31
8-K 2018-10-23
8-K 2018-09-28
8-K 2018-08-21
8-K 2018-07-30
8-K 2018-05-23
8-K 2018-04-24
8-K 2018-01-30
8-K 2018-01-08

Illumina Financials

ILMN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash2372112494102612303032603163434344437846927125196758306365345915527697559527957359811,2191,3541,2251,5601,3441,3461,1442,2701,9431,815
Accounts Receivable148171166182193169174202189218215211207235239293259277289350369413386403372382381368372383411400395433514457470541
Inventory119130142151143139129129134148159168168160154164178199191205224234271288311312300299309327333350362374386412420417
PP&E1221261301251301352801431481551661871871943802102302484802813033096093858139531,0401,0801,2081,2531,3471,4271,5121,5421,5961,4061,4091,411
Assets1,6421,7251,8392,1232,2572,1472,1962,3012,3492,4382,5662,7442,8232,8183,0193,0543,0353,2783,3403,4993,7033,7343,6883,7943,9854,2284,2814,5984,8585,0465,2575,5425,8516,7596,9597,3906,9737,089
Accounts Payable58606766585250605775667768637486929683107108123139155251134138142175158160151149156184137139143
Long-Term Debt1,4291,6361,8531,8502,0222,0232,1791,1101,0911,0231,0321,0421,0491,0561,1741,1821,1921,3301,3481,9671,9971,7431,1201,131
Liabilities6056176411,0591,0891,1121,1211,1411,1681,2161,2481,4321,4351,4431,4861,4801,9552,0041,8771,8761,9091,8391,8031,9291,9882,0832,0472,1432,1912,5082,5342,5943,2563,2013,4052,6412,650
Stockholders' Equity1,0371,1081,1981,0641,1681,0361,0751,1601,1811,2221,3191,3121,3891,3741,5331,5741,0801,2741,4631,6231,7941,8491,9912,0562,2402,1972,5512,7152,8552,7493,0083,2573,5033,7583,9854,3324,439
Income Statement ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Revenue212237246283312235250273281286309331346357387421512481512539539550592572600607619598662714778782830853867846838907
Cost of Revenue6680959410878799210190106112144147128142147147241641631634017517618138230228232235244255256277262265259
Gross Profit146157166188224157171181217196204219247210259278301334385375376388410397424426419368434482542538575597590584573648
R&D444546505650464971545761687177778385143929699114124125126130145130134137137151159169166151
SG&A54556266806661686970808510496112110115120122116124137147149149139146163169167175183197197211202189
Tax17191212188914181432-2513640241419394139133228413727155212316624324495336
Net Income3035382431201226293072-233631816047931531371021181049012012912436712816368208209199210233296234
Cash Flow ($MM)2010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash Operating618189719010865965179888983127371781461416717118124040217150280168178235294255295292198143267
Cash Investing-95-70-153-27267-43-142-10-1719-65247-101-151-144115-44-333-154-142-39229-4444-341-17316335-97-31512-537-94098879-218
Cash Financing122722552-188834-30-8-6-136-7544-86-137550-1328-181-253-12-6334-163-8624-5-1096730651-60-549-173